/ Dr. Kingsley Chin
Kingsley R Chin MD, MBA
Founder, Chairman & CEO
KIC Ventures
Transforming Spine Surgery with Visionary Leadership
Meet Kingsley R Chin MD MBA
Dr. Kingsley R. Chin is the Founder, Chairman, and CEO of KIC Ventures, a private equity healthtech investment firm, where he directs the firm’s investment strategy, governance, and overall strategic direction. Dr. Chin oversees KIC Ventures' diverse portfolio of majority-owned spine companies, driving innovation and commercialization in spine surgery technologies. He also leads the firm’s executive management committees, ensuring alignment with its long-term vision and operational excellence.
Since the inception of KIC LLC, Dr. Chin has overseen more than 10 strategic transactions, beginning with the sale of MANTIS LLC to Stryker and including notable acquisitions such as the AxioMed viscoelastic disc replacement platform. These efforts have contributed to remarkable growth in equity value, achieving an increase of over 3,000x. With estimated assets under management (AUM) of $1 to $3 billion, KIC Ventures has established itself as a global leader in spine technology innovation under Dr. Chin’s leadership.
His unique blend of academic, clinical, and business expertise—with degrees from Columbia University, Harvard Medical School, and Harvard Business School, a tenure as Chief of Spine Surgery at the University of Pennsylvania, and experience as a former experienced management consultant at Accenture in New York City—guides his strategic oversight.
"Many men pray to God to gain success and money; other men are called by God to spend money to help others succeed."
-Kingsley R Chin MD MBA
Revolutionizing Spine Surgery Technologies
Driven by an unwavering entrepreneurial spirit and early business experience in New York City, Dr. Chin’s journey into health technology innovations began during his formative years as an orthopedic resident at Harvard Medical School. Inspired by his professors' groundbreaking approaches to orthopedic technologies, Dr. Chin secured his first patent in 2000, setting the stage for a career marked by transformative advancements.
Harvard Orthopedic Residency: Dr. James H Herndon (left), Dr. Kingsley R Chin (middle) and Dr. Thomas S Thornhill (right)
In 2004, Dr. Chin introduced the MANTIS percutaneous pedicle screw system—a landmark innovation that became a cornerstone in the evolution of spine surgery technologies. This achievement was more than just a technical success; it represented a paradigm shift from traditional open spine surgeries to percutaneous, less invasive procedures, opening new possibilities for patient care.
Dr. Kingsley R Chin MD MBA
With over 30 years of experience, Dr. Chin remains steadfast in his dedication to advancing outpatient spine surgery. His proprietary Less Exposure Spine Surgery (LESS™) technologies embody not only his pursuit of surgical excellence but also his deep commitment to sharing knowledge, fostering collaboration, and improving patient outcomes. Dr. Chin's work continues to redefine the landscape of less invasive outpatient spine surgery, driven by a relentless mission to advance spine technologies and make a lasting impact on the field, improving the lives of countless patients worldwide.
Dr. Kingsley R Chin (left) and Dr. Anthony T Yeung the pioneering inventor of the Yeung endoscopic spine surgery (YESS) system
Diverse Experience and Business Acumen
Transitioning to the corporate world, Dr. Chin honed his business skills at prestigious institutions like AT&T Bell Labs as an intern and as an experienced management consultant at Accenture New York City, where he provided management information systems consulting for Goldman Sachs and Cigna Insurance. This early experience gave him a unique blend of engineering expertise and business acumen, setting the stage for his groundbreaking entrepreneurial leadership in healthtech after becoming a spine surgeon.
A Remarkable Journey
Dr. Chin’s journey from a small town in Jamaica to becoming a CEO at the forefront of spine surgery technology is truly inspirational. Raised in Buff Bay by a single mother, he learned the values of resilience and determination early on. His journey took a significant turn with a scholarship to Columbia University, where he excelled both academically and athletically, earning recognition as an engineering standout and Ivy League Player of the Year in soccer. He was also elected Student Government president of the Senior Class, further demonstrating his leadership abilities. He credits his success to his ability to overcome adversity and make quick decisions to seize opportunities.
Dr. Kingsley R Chin (left), Dr. Henry Bohlman (middle) and Dr. Augustus White (right)
.jpg)
Dr. Kingsley R Chin and Stryker's Mantis Technology while at NASS
Overcoming Challenges and Driving Growth
Despite recent challenges, including navigating the Covid-19 pandemic and defending against anti-kickback charges by the Department of Justice dating back to 2013, Dr. Chin’s resilience and commitment to excellence remained unwavering. In 2023, he signed a civil agreement, and in 2024, successfully had money laundering charges dismissed. Throughout this period, KIC Ventures’ indispensable leadership remained intact.
Dr. Chin’s insight into market niches like interventional pain management has positioned KIC Ventures for sustainable growth, with revenues increasing over 40% year-over-year since 2021. Under his visionary leadership, the company’s entry into the interventional pain management niche, focused on ambulatory surgery center physician owners, and the acquisition of AxioMed viscoelastic disc replacement and NanoFuse 45S5 Bioglass Biologics, has further solidified his role as an innovator poised to transform traditional spine surgeries and improve patient outcomes.
Proven Value Growth
Officially registered as a Series LLC in 2005, KIC LLC was built on the foundation of Dr. Kingsley R. Chin’s patents, forming a portfolio of companies aimed at revolutionizing spine care through less invasive techniques.
In 2006, Dr. Chin invested $100,000 to launch Spinefrontier Inc., a portfolio company dedicated to cutting-edge spine technologies. This strategic move followed the notable 2005 acquisition of MANTIS LLC by Stryker, a Fortune 500 company, further underscoring the immense potential of Dr. Chin’s innovations and solidifying his status as a pioneer in the field.
In 2013, Dr. Chin expanded his vision by establishing KIC Ventures as the venture arm of KIC, accelerating the innovation and commercialization of transformative spine technologies. His strategic vision and dedication have since led him to invest over $40 million of his own capital, while attracting an additional $25 million from external investors.
Today, KIC Ventures is offering Series A shares at a valuation of $300 million, with Dr. Chin owning more than 50%, reflecting an impressive 3,000x return on his initial investment. With estimated assets under management (AUM) of $1 to $3 billion, KIC Ventures has established itself as a pioneering private equity healthtech investment firm, holding the world’s largest portfolio of majority-owned spine companies exclusively focused on spine surgery, and positioning itself as a global leader in the industry.
A Prime Opportunity for Investors
As you explore investment options, it’s worth considering the journey that has brought KIC Ventures to this pivotal point. KIC Ventures presents a unique and compelling opportunity for investors. With proven leadership, minimized risks, and a clear path for global expansion, the anticipated 2025 release of AxioMed's lumbar disc replacement to U.S. surgeons is expected to further accelerate growth, positioning the company for a multibillion-dollar valuation.
As a private equity healthtech investment firm, KIC Ventures operates with a long-term vision, prioritizing the sustainability and future potential of the technologies we acquire for spine surgeons. Our strategic acquisition of AxioMed in 2014 was made not for immediate returns but for its enduring value. Similarly, our 2018 acquisition of NanoFuse Biologics reflects our commitment to long-term growth over short-term gains. We place ultimate value on peer-reviewed data and collaboration with our spine colleagues to uncover the truth about the sustainability of our technologies—a vital, yet often undervalued, aspect of our approach.
NANISX, one of our portfolio companies, exemplifies our success in commercialization, adoption, and revenue growth, consistently achieving profitability since 2021 and maintaining a positive EBITDA. This track record reinforces the strength of our approach and highlights the significant opportunities that lie ahead.
By allocating up to 20% of your SDIRA to this Series A round, you’re not just backing a company—you’re investing in a vision built on a track record of success and groundbreaking innovation. Using your SDIRA for this investment offers a strategic advantage: it allows for tax-deferred growth, maximizing the potential returns on your investment. By leveraging your SDIRA, you align your retirement savings with a high-growth opportunity, benefiting from the innovation-driven success of KIC Ventures while positioning yourself for significant long-term gains.
The Series A round offers a chance to be part of a vision built on a strong foundation of success and innovation, with the potential for substantial returns as we continue to advance the field of spine surgery.
Why Investors Trust Dr. Kingsley R. Chin
Dr. Kingsley R. Chin’s extraordinary journey from a small town in Jamaica to a pioneering CEO in spine surgery technology is a testament to his resilience, relentless determination, and visionary leadership. His early life instilled values of hard work, perseverance, and family, while his academic achievements reflect his intellectual curiosity.
Dr. Chin’s proven track record of innovation, combined with his deep understanding of both medical and business realms, makes him a leader that investors find compelling. Dr. Kingsley R. Chin and KIC Ventures are transforming spine technologies – shaping the future of outpatient spine surgery.
Education
-
B.A Mathematics, Columbia University
-
B.S. Electrical, Electronics and Communications Engineering, Columbia University
-
MD Doctor of Medicine (Honors), Harvard Medical School
-
MBA Healthcare Management, Ball State University
-
Degree in Executive Leadership, Harvard Business School
-
Residency in Orthopedic Surgery, Massachusetts General Hospital, Harvard University
-
Orthopedic Reconstructive Surgery Fellowship, Harvard University
-
Henry Bohlman Spine Fellowship, University Hospitals of Cleveland, Case Western Reserve School of Medicine
This book is a potent initiator and energizer. It takes a simplified but holistic approach to success that will motivate and instigate.
From the Foreword
This textbook aims to convey both the art and science of interventional spine care. The editors are all distinguished clinicians and respected researchers.
Preface
"Patients deserve the least aggressive care feasible... when this is accomplished, an algorithmic approach can be offered that adequately balances the potential outcomes and known side effects or complications. "
Curtis W. Slipman
2007
Soundtrack
To our knowledge, this marks the first time a book will be accompanied by a soundtrack... The Prove Yourself Trilogy Album Soundtrack, set to accompany the Prove Yourself book, features three unique albums.
-
Go Get It
-
Fight
-
JamaicHer